MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • MDS Virtual Congress 2021

    Cognitive-driven ADL impairment as a predictor for PDD

    I. Liepelt-Scarfone, M. Bode, K. Brockmann, T. Gasser, K. Michaelis, S. Nussbaum, HC. Nuerk, C. Schulte, W. Maetzler, M. Zimmermann, D. Berg, S. Becker (Tübingen, Germany)

    Objective: To evaluate whether Parkinson’s disease (PD) patients with mild activity of daily living (ADL) impairment are at higher risk for developing dementia (PDD). Background:…
  • MDS Virtual Congress 2021

    Maximising UPDRS information while minimising assessment time

    G. Morinan, J. Tang, J. O'Keeffe (London, United Kingdom)

    Objective: The gold standard for measuring disease severity in PD (Parkinson’s Disease) is the MDS-UPDRS (Movement Disorder Society - Unified PD Rating Scale) [1]. However,…
  • MDS Virtual Congress 2020

    Concordance of different evaluation approaches of non-motor symptoms in patients with cervical dystonia

    V. Han, K. Kulcsarova, J. Ventosa, Z. Gdovinova, M. Skorvanek (Kosice, Slovakia)

    Objective: The aim of our study was to assess the concordance of different evaluation approaches of non-motor symptoms (NMS) in patients with cervical dystonia (CD).…
  • MDS Virtual Congress 2020

    What Matters Most to Individuals with Parkinson’s Disease: Results from Qualitative Interviews

    A. Arky, C. Zizzi, E.R Dorsey, C. Heatwole (Rochester, NY, USA)

    Objective: To use interviews from individuals with Parkinson's disease (PD) to better understand the symptomology of the disease. Background: It is important to understand the…
  • MDS Virtual Congress 2020

    Development and Validation of the Orthostatic Tremor Severity and Disability Scale (OT-10)

    J. Vizcarra, A. Merola, D. Torres-Russotto, G. Stebbins, A. Wagle Shukla, A. Hassan, L. Marsili, J. Krauss, R. Elble, G. Deuschl, A. Espay (Atlanta, GA, USA)

    Objective: To develop and validate a severity and disability self-administered scale for orthostatic tremor (OT). Background: OT is characterized by a 13-18 Hz tremor in…
  • MDS Virtual Congress 2020

    Patient experience interviews to inform a digital assessment of Parkinson’s disease

    A. Thomann, D. Nobbs, H. Staunton, D. Trundell, S. Winkelmann, T. Kilchenmann, C. Lansdall, C. Gossens, F. Lipsmeier, M. Lindemann, K. Taylor (Basel, Switzerland)

    Objective: The aim of this study is to generate a conceptual framework that maps patient-relevant functional limitations to behavioral measures that can be captured with…
  • MDS Virtual Congress 2020

    Quality of Life Study of Patients Living with Parkinson’s Disesae in Sub-Saharan Africa

    M. Fall, T.M Sarr (Dakar, Senegal)

    Objective: The objective is to assess the quality of life of patients with Parkinson's disease followed in Senegal. Background: Parkinson's disease is a neurodegenerative disease,…
  • MDS Virtual Congress 2020

    Establishment of a Visual Analog Scale (VAS) for DBS Programming (VISUAL – STIM Trial)

    C. Palleis, M. Gehmeyr, J. Mehrkens, K. Boetzel, T. Koeglsperger (Munich, Germany)

    Objective: With this study, we wanted to demonstrate a new strategy to adjust stimulation parameters and lead configurations, using a visual analog scale. Background: Deep brain…
  • MDS Virtual Congress 2020

    Type 2 diabetes mellitus may worsen severity of motor symptoms in people with Parkinson’s disease

    A. Ben-Joseph, T. Haque, D. Gallagher, C. Budu, R. Chaudhuri, C. Simonet, A. Noyce (London, United Kingdom)

    Objective: We aimed to determine whether co-morbid type 2 diabetes mellitus (T2DM) would impact the motor or non-motor symptom severity in people with Parkinson’s (PwP).…
  • MDS Virtual Congress 2020

    Care-giver Burden in Parkinson’s Disease and Atypical Parkinsonism in Indian Patients Using Zarit Burden Interview scale

    D. Hoskere Sreenivasa, M. Philip, P. Kukkle (Bangalore, India)

    Objective: To assess the impact of Parkinson’s disease (PD) and atypical-parkinsonism (AP) on primary care giver among Indian population using Zarit Burden Interview (ZBI) scale.…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley